- Home
- IVDA vs RDHL Comparison
IVDA vs RDHL Comparison
Compare IVDA & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVDA | RDHL |
|---|---|---|
| Founded | 2003 | 2009 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7M | 3.7M |
| IPO Year | 2015 | 2012 |
Fundamental Metrics
Financial Performance| Metric | IVDA | RDHL |
|---|---|---|
| Price | $0.21 | $0.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 127.7K | 88.4K |
| Earning Date | 11-24-2026 | 09-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.38 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,468,279.00 | N/A |
| Revenue This Year | N/A | $17,592.31 |
| Revenue Next Year | N/A | $25.89 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 132.98 | N/A |
| 52 Week Low | $0.18 | $0.36 |
| 52 Week High | $1.52 | $1.60 |
Technical Indicators
Market Signals| Indicator | IVDA | RDHL |
|---|---|---|
| Relative Strength Index (RSI) | 41.84 | 38.36 |
| Support Level | $0.18 | $0.38 |
| Resistance Level | $0.34 | $0.47 |
| Average True Range (ATR) | 0.02 | 0.04 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 47.46 | 19.89 |
Price Performance
Historical ComparisonAbout IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products). Geographically, the company operates in USA and Taiwan, majority of its revenue is generated from Taiwan.
About RDHL Redhill Biopharma Ltd.
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.